KalVista Pharmaceuticals (KALV) Return on Sales Growth (3y) (2019 - 2020)
KalVista Pharmaceuticals (KALV) Return on Sales Growth (3y) (2019 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn | 1.00 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2020 | 43.00 |
| Jan 31, 2020 | 23.00 |
| Oct 31, 2019 | 18.00 |
| Jul 31, 2019 | 2.00 |